In patients with HCV genotype 2 or 3 infection and RVR 14 weeks treatment is noninferior to 24 weeks: pooled analysis of two Scandinavian trials

Research output: Contribution to journalJournal articleResearchpeer-review

O. Dalgard, K. Bjoro, Helmer Ring Larsen, H. Verbaan

Original languageEnglish
JournalEuropean Journal of Gastroenterology and Hepatology
Issue number5
Pages (from-to)552-556
Number of pages4
Publication statusPublished - 1 May 2010

ID: 33788426